title: Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population.
abstract: Previous mutational analysis for BRCA gene mutations in sporadic ovarian cancer occurring in Chinese patients in Hong Kong identified six germline BRCA1 mutations and one germline BRCA2 mutation, six of which were novel (Khoo et al., 2000). Knowledge of BRCA gene mutations in the Chinese population is relatively scant. In this study, we focussed on whether any of these mutations could be recurrent in our Chinese population, making use of archival paraffin embedded tissue. A consecutive series of 214 ovarian cancer cases, half of Southern Chinese origin from Hong Kong whilst the other half of Northern Chinese origin from Beijing were used for the study. We identified one further novel mutation, 1081delG, in BRCA1. This was found to occur in two unrelated individuals with shared haplotype as revealed by allelotype analysis, thus demonstrating founder effect. Two other recurrent mutations were also identified, the 2371-2372delTG mutation in BRCA1 and the 3337C>T mutation in BRCA2 recurring in two and three unrelated individuals respectively, giving an overall prevalence 4.7% of recurrent BRCA mutations in ovarian cancer in the Southern Chinese population. Most importantly, all our recurrent mutation carriers were identified from Southern Chinese patients from Hong Kong whilst such mutations were absent in samples from the Northern Chinese. Our findings indicate possible heterogeneity in the BRCA genotype between Northern and Southern Chinese. The identification of a founder mutation and two recurrent mutations moreover, has important implications towards screening strategies for breast and ovarian cancer among Chinese of southern ancestral origin who are now dispersed throughout the world.
authors.affiliation: Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
authors.forename: Ui-Soon
authors.initials: US
authors.lastname: Khoo
authors.forename: Kelvin Y K
authors.initials: KY
authors.lastname: Chan
authors.forename: Annie N Y
authors.initials: AN
authors.lastname: Cheung
authors.forename: W C
authors.initials: WC
authors.lastname: Xue
authors.forename: D H
authors.initials: DH
authors.lastname: Shen
authors.forename: K Y
authors.initials: KY
authors.lastname: Fung
authors.forename: Hextan Y S
authors.initials: HY
authors.lastname: Ngan
authors.forename: K W
authors.initials: KW
authors.lastname: Choy
authors.forename: C P
authors.initials: CP
authors.lastname: Pang
authors.forename: C S P
authors.initials: CS
authors.lastname: Poon
authors.forename: A Y A
authors.initials: AY
authors.lastname: Poon
authors.forename: Hilmi
authors.initials: H
authors.lastname: Ozcelik
mesh_terms: D000328:Adult; D000368:Aged; D044466:Asian People / Q000235:genetics*; D002277:Carcinoma / Q000235:genetics* / Q000473:pathology; D002681:China / Q000208:ethnology; D005260:Female; D018703:Founder Effect; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D005828:Genetics, Population; D018095:Germ-Line Mutation / Q000235:genetics*; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000473:pathology; D013030:Spain / Q000453:epidemiology